Skip to main content
. 2015 May 19;10(5):e0127352. doi: 10.1371/journal.pone.0127352

Fig 4. The levels of selected biomarkers in liver and serum.

Fig 4

(A) Hepatic S100A9, SREBF1, TBX21, and GIMAP4 protein levels in control, NAFL, NASH and NAFL + T2DM groups. (B) Serum levels of SREBF1, TBX21, GIMAP4, S100A9, and CK18 protein in the control, NAFL, NASH, NAFL+T2DM groups. *, P < 0.05 compared with the control group; §, P < 0.05 compared with the NAFL group.